HDAC Inhibition Suppresses Primary Immune Responses, Enhances Secondary Immune Responses, and Abrogates Autoimmunity During Tumor Immunotherapy

Histone deacetylase inhibitors (HDACi) can modulate innate antiviral responses and render tumors more susceptible to oncolytic viruses (OVs); however, their effects on adaptive immunity in this context are largely unknown. Our present study reveals an unexpected property of the HDACi MS-275 that enh...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bridle, Byram W, Chen, Lan, Lemay, Chantal G, Diallo, Jean-Simon, Pol, Jonathan, Nguyen, Andrew, Capretta, Alfredo, He, Rongqiao, Bramson, Jonathan L, Bell, John C, Lichty, Brian D, Wan, Yonghong
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3616544/
https://ncbi.nlm.nih.gov/pubmed/23295947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2012.265
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados